WellPrept
Decision Aid

Watch it, or take it out?

A scan picked up a small spot on one of your adrenal glands. The workup is done. The mass is small, looks benign, and is not making extra hormones. Now you choose between keeping an eye on it with repeat scans or having surgery to remove it.

Last reviewed 2026-06-05 Reading time ~7 min Print-friendly
A note before you start

This tool does not pick for you. Your urologist or endocrinologist will help you choose.

This page can help you sort out your thoughts before your visit. Use it to ask sharper questions during the visit. Both watching the mass and having it out are reasonable, well-studied choices for a small, calm-looking mass that is not making extra hormones. The right pick depends on your numbers, your other medical history, and how you feel about scans and surgery. For the full background on adrenal masses and the workup that gets a patient to this page, see the WellPrept adrenal mass guide.

Chapter 1 · The decision

Is this aid the right fit for you?

This page is for one specific situation. If your case fits, you are choosing between the two paths below. If it does not fit, the decision is not yours alone to make and your doctor will guide you to a different plan.

This aid fits you if all of these are true

  • A CT or MRI showed a mass on one of your adrenal glands, found by accident on a scan done for another reason.
  • The mass is smaller than 4 cm.
  • On a dedicated adrenal CT (or MRI), the mass looks like a typical benign adenoma. The radiologist used the words "lipid-rich adenoma," "low density," "high washout," or "consistent with adenoma."
  • Your hormone workup is normal. That means a normal overnight dexamethasone suppression test, normal plasma or urine metanephrines, and (if you have high blood pressure or low potassium) a normal aldosterone-to-renin ratio.
  • You do not have a prior cancer that this mass might be a spread of. If you do have a prior cancer, the team has already worked that question out and ruled out metastasis.

This aid does NOT fit you if any of these are true

  • The mass is making extra hormones. That includes a pheochromocytoma (catecholamines), a cortisol-producing adenoma, an aldosterone-producing adenoma, or an androgen-producing tumor. Surgery is the right answer, not a choice between watching and operating.
  • The mass looks suspicious on imaging. That includes mass size above 4 cm, irregular edges, mixed density inside the mass, signs of growth into nearby vessels or organs, or imaging features your radiologist flagged as concerning. The team will move toward surgery and a more focused workup, not surveillance.
  • You have a known cancer elsewhere and this mass might be a spread of it. The next step is a different workup, not a surveillance-versus-surgery choice.
  • You have a hereditary syndrome that affects the adrenal glands (such as MEN2 or VHL). The syndrome sets your care plan. It is best handled at a center with experience in those conditions.

If your situation does not fit this page, the choice you face is a different one. Read the full adrenal mass guide and bring your questions to your visit.

What your doctor brings to the choice

Your urologist or endocrinologist will look at the size of the mass, the exact density and washout numbers from your scan, your hormone results, your age, your other medical conditions, and your surgical risk. They will share which way they lean and why. They will also be honest about the parts where reasonable doctors disagree (chapter 3). This page is for after that talk, when both watching and operating are still on the table.

Chapter 2 · Your options

Compare the two paths

The columns sit side by side in no particular order. Reading down a column tells you about one option, and reading across a row compares the two on a single point.

Option 1Surveillance Option 2Adrenalectomy
What it is Keep the mass in place and watch it over time with a repeat scan and repeat hormone tests on a set schedule. No surgery unless something changes. Have the whole adrenal gland (with the mass inside it) removed in a planned operation. Most are done with small incisions through a scope or a robot.
Setting Outpatient. Follow-up scans and labs are scheduled at your clinic or imaging center. Operating room under general anesthesia. Most patients go home the same day or after one night in the hospital.
How well it works (what "works" means here) For this kind of small, benign-appearing, nonworking mass, the risk of it growing or starting to make hormones over the next several years is in the low single digits. Surveillance catches that small subset early. Surgery removes the mass for good. On final pathology, around 95% of these masses turn out to be benign adenomas, which matches what the scan suggested. Surgery also takes care of the small chance that the imaging or hormone workup missed something subtle.
Recovery time None. You go back to your usual life right away. Most patients are back at desk work in 1 to 3 weeks and back to heavy activity in 3 to 6 weeks. Most pain is well controlled after the first few days.
Best fit when… The mass is small and the imaging is classic for a benign adenoma. You are comfortable with the idea of a planned scan and a planned set of labs once or twice over the next few years. You would rather avoid surgery if you can. You want a definite answer from pathology rather than a watch-and-wait plan. You are healthy enough for surgery without much added risk. Repeat scans would be a source of worry for you, or you live somewhere that makes follow-up hard.
Anxiety and lifestyle ask You will know there is a small mass inside you. Some people set this aside without much trouble. Others find the wait between scans hard. You go through one defined event, surgery and a few weeks of recovery, and then it is behind you.
Cost (US, out of pocket) Lower in the short run. The cost is the scans and labs over time, plus any co-pays. Most surveillance plans are covered by insurance as medically appropriate follow-up. Higher up front. Most adrenalectomy for an appropriate indication is covered by insurance, but co-pays, deductibles, and time off work add up. Ask your team and your insurance for your actual out-of-pocket cost before the date is set.
Diagnostic certainty The diagnosis stays a strong best guess based on the scan and labs. A small fraction of masses that look like adenomas turn out to be something else, but for this kind of mass that fraction is small. The pathologist looks at the actual tissue under a microscope. You get a final answer that imaging cannot give.
Risk of catching a cancer late Low for this kind of mass. The point of repeat scans is to catch the rare change early. If the mass grows or its features change, the plan shifts and surgery is reconsidered. Very low. Surgery removes the mass, and pathology confirms what it was. A mass that turns out to be cancer has already been taken out.
Main risks Repeated CT scans expose you to a small amount of radiation over time. The mass could grow or start making hormones, and a small fraction of patients end up needing surgery anyway. Bleeding, infection, and injury to nearby structures (the spleen, pancreas, liver, kidney, or large blood vessels). Conversion from a scope or robot to an open operation in around 2 to 5%. Lifelong adrenal insufficiency is rare when only one gland is removed.
What happens to the other adrenal gland Nothing. Both glands stay in place and keep working. The other adrenal gland is left alone and takes over the work of both. For a nonworking adenoma, no hormone replacement is usually needed after surgery.
Usually considered when… The mass meets all the "benign and quiet" criteria, you are at any age, and you are willing to come back for the planned scans. The mass is at the larger end (close to 4 cm), borderline imaging features make the team uneasy, you have a strong personal preference for a definite answer, or repeat scans would be a meaningful burden on your life.

A note on what surveillance actually looks like

For a small, benign-appearing, nonworking mass, current guidelines suggest a single repeat scan at 6 to 12 months. This confirms the mass is stable. Hormone testing is often repeated at the 1-year mark. It is sometimes done again at 2 and 5 years, especially if anything in your history changes. If the mass is the same size and look on the repeat scan, many patients can stop further imaging. Care then goes back to their primary care doctor. This is a shift from the older practice of yearly scans for many years.

Chapter 3 · The honest disagreements

Where doctors disagree

Two thoughtful doctors can look at the same patient and pick a different path. These are the points where they often differ:

  • The size cutoff for surgery. The most common rule of thumb is to recommend surgery once a nonworking mass crosses 4 cm. Some experienced centers will operate at 3 cm, especially in younger patients with low surgical risk. Other centers wait until 6 cm in patients with higher surgical risk and classic benign imaging. None of these cutoffs is a hard line. The 4 cm number is the most quoted, but your team may use a different one. Ask them what number they use and why.
  • How long to keep doing scans. Older practice was a CT every year, sometimes for life. Current guidelines have moved toward a single repeat scan at 6 to 12 months and then stopping if the mass is stable. Some doctors still favor an additional scan at 2 years, especially for masses at the higher end of the small range. Others stop sooner. The choice depends on the mass, your overall risk picture, and your own comfort.
  • Whether to repeat hormone tests at 5 years. A small fraction of nonworking adenomas slowly start to make hormones over time. Some experts repeat the hormone screen at 1, 2, and 5 years to catch this early. Others repeat tests only if symptoms appear or if a routine blood pressure or potassium reading goes off. Either approach is defensible.
  • The "I just want it out" patient. Some patients cannot stop thinking about the mass and would lose meaningful sleep over it. The mass itself is low risk, but years of worry weigh on a person. A urologist or endocrinologist may agree to operate on a mass that does not meet a strict size or hormone trigger, when surgery is low risk for that patient and the patient understands the trade. Other doctors are slower to operate without a clear medical reason, because every surgery carries risks of its own. Both views are reasonable.

If you are weighing the two options, ask your doctor which they pick and why for your case. If the choice feels close, get a second opinion.

Chapter 4 · Your trade-offs

What you are weighing

There is no single right answer here. As you read the table, ask yourself:

  • How well do I handle waiting between scans? Will I think about this mass every week, or can I set it aside?
  • Is the mass close to 4 cm, or well under it? Closer to 4 cm tips a few patients toward surgery; well under tips most toward watching.
  • How healthy am I overall? Surgery adds risk for people with serious heart or lung conditions; for healthier people that added risk is small.
  • How easy is it for me to come back for scans and labs on the planned schedule? Do I live near my clinic, or would follow-up be hard to fit in?
  • How do I feel about the small chance that the workup missed something? Some people trade a few weeks of recovery for the certainty of a pathology report.
  • What does my insurance cover for each path? Have I asked for my actual out-of-pocket cost?
  • If I chose surveillance, how would I feel about a scan a year from now showing the mass had grown? Surgery would then become the plan.
  • If I chose surgery, how would I feel about going through the operation and then learning it really was just a benign adenoma? That is the same answer the scan already suggested.
Chapter 5 · Take these to your appointment

Good questions to ask

Print this page or write these down. The first set is for your urologist or endocrine surgeon. The second set is for your endocrinologist or primary care doctor. Use the space at the bottom for your own questions.

For your urologist or endocrine surgeon

  1. For my exact size and imaging numbers, which option do you lean toward, and why?
  2. How many adrenalectomies do you do in a year? How many of those are minimally invasive?
  3. If I picked surgery, would you plan to go in from the front (transabdominal), from the back (posterior retroperitoneal), or with a robot? Why that approach for me?
  4. What is your rate of needing to switch from a scope or robot to an open operation?
  5. What does my recovery realistically look like in the first week, the first month, and at three months?

For your endocrinologist or primary care doctor

  1. If I picked surveillance, what exactly does my schedule look like? When is my next scan, and when are my next labs?
  2. What would change your mind from "keep watching" to "time to operate"?
  3. How sure are we that my hormone workup is fully normal? Is there any test you would want to repeat?
  4. If the mass grew or started making hormones a year or two from now, what would the plan look like at that point?
  5. If you were in my exact situation, what would you do?

My own questions:

Where this information comes from

  1. Fassnacht M, et al. European Society of Endocrinology and European Network for the Study of Adrenal Tumors (ESE/ENSAT) Clinical Practice Guideline on the management of adrenal incidentalomas. European Journal of Endocrinology, 2023;189(1):G1-G42.
  2. Yip L, et al. American Association of Endocrine Surgeons Guidelines for Adrenalectomy. JAMA Surgery, 2022;157(10):870-885.
  3. Zeiger MA, et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas. Endocrine Practice, updated position statement.
  4. Lenders JWM, et al. Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism, 2014;99(6):1915-1942, and subsequent updates.
  5. Boland GW, et al. Characterization of adrenal masses by using washout CT: foundational evidence on absolute and relative washout thresholds. Radiology, established reference.
  6. Sherlock M, et al. Adrenal incidentaloma. Endocrine Reviews, 2020;41(6):775-820.
  7. WellPrept clinical brief: Adrenal mass / adrenal incidentaloma, 2026-05-05 build, with 2026 review pass.
This decision aid does not recommend one option over another. Outcome numbers reflect typical published ranges; your exact mass size, imaging numbers, hormone results, and overall health may make one option more or less appropriate for you. Your urologist, endocrine surgeon, and endocrinologist are the right people to translate this material to your situation.

WellPrept Decision Aid · adrenal-mass-incidentaloma-choice · v1 · next review 2027-06-05